Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, Sutton, UK.
Bioorg Med Chem. 2013 Sep 15;21(18):5707-24. doi: 10.1016/j.bmc.2013.07.021. Epub 2013 Jul 19.
With the success of protein kinase inhibitors as drugs to target cancer, there is a continued need for new kinase inhibitor scaffolds. We have investigated the synthesis and kinase inhibition of new heteroaryl-substituted diazaspirocyclic compounds that mimic ATP. Versatile syntheses of substituted diazaspirocycles through ring-closing metathesis were demonstrated. Diazaspirocycles directly linked to heteroaromatic hinge binder groups provided ligand efficient inhibitors of multiple kinases, suitable as starting points for further optimization. The binding modes of representative diazaspirocyclic motifs were confirmed by protein crystallography. Selectivity profiles were influenced by the hinge binder group and the interactions of basic nitrogen atoms in the scaffold with acidic side-chains of residues in the ATP pocket. The introduction of more complex substitution to the diazaspirocycles increased potency and varied the selectivity profiles of these initial hits through engagement of the P-loop and changes to the spirocycle conformation, demonstrating the potential of these core scaffolds for future application to kinase inhibitor discovery.
随着蛋白激酶抑制剂作为癌症治疗靶点的成功,人们对新的激酶抑制剂支架的需求持续存在。我们研究了新的杂芳基取代的二氮杂螺环化合物的合成和激酶抑制作用,这些化合物模拟了 ATP。通过闭环复分解反应展示了取代的二氮杂螺环的多功能合成。直接连接到杂芳环铰链结合基团的二氮杂螺环提供了多种激酶的有效配体抑制剂,可作为进一步优化的起点。通过蛋白质晶体学证实了代表性二氮杂螺环基序的结合模式。选择性特征受 hinge binder 基团和支架中碱性氮原子与 ATP 口袋中酸性侧链残基的相互作用的影响。在二氮杂螺环上引入更复杂的取代基,通过与 P 环的结合以及对螺环构象的改变,增加了这些初始命中物的效力,并改变了它们的选择性特征,这表明这些核心支架在未来激酶抑制剂发现方面具有应用潜力。